heart transplant CareDx Q4 Revenues Up 64 Percent The company reported $58.6 million in total revenues for the quarter and said testing services revenues rose 73 percent year over year. Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium The researchers hope that donor-derived cell-free DNA testing to monitor rejection can help relieve racial disparities in heart transplant outcomes. CareDx Preliminary Q4 Revenues Up 63 Percent, Beat Estimates CareDx expects fourth quarter revenues of $58.4 million to $58.6 million, an increase of approximately 63 percent compared to $35.8 million in Q4 2019. CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests The company's AlloSure Kidney test received coverage, along with its AlloSure Heart test when used with the firm's AlloMap test. CareDx Q3 Revenues Up 58 Percent The company reported $53.4 million in total revenues for the quarter and said testing services revenues rose 61 percent year over year. Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Apr 30, 2020 CareDx Q1 Revenues Up 48 Percent Apr 9, 2020 CareDx, Stanford Sue TAI Diagnostics for Patent Infringement Feb 27, 2020 CareDx Q4 Revenues Up 52 Percent Jan 22, 2020 Heart Transplant Monitoring Test From TAI Diagnostics Validated in New Study Premium Nov 19, 2019 Upgrades to CareDx's AlloSure Test Enable Earlier Detection of Transplant Rejection Premium Oct 31, 2019 CareDx Q3 Revenues Up 60 Percent Sep 24, 2019 CareDx, NanoString Collaborate to Develop Organ Transplant Rejection Test Aug 22, 2019 CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD Aug 1, 2019 CareDx Q2 Revenues Up 76 Percent May 9, 2019 CareDx Plans to Launch New Multi-Modal Kidney Transplant Dx, Incorporating Predictive AI Premium May 8, 2019 CareDx Q1 Revenues Up 84 Percent May 3, 2019 Anthem Blue Cross Brings CareDx's AlloMap Heart Transplant Test In Network Apr 25, 2019 CareDx Acquires Transplant Management Firm for $16M in Cash Mar 6, 2019 CareDx Q4 Revenues Increase 88 Percent Feb 25, 2019 CareDx Expands AlloSure Transplant Test to Lung, Starting With Compassionate Use Premium Feb 15, 2019 Jefferies Initiates Coverage of CareDx With Buy Rating Jan 7, 2019 CareDx Preliminary Q4 Revenues Up at Least 85 Percent Nov 8, 2018 CareDx Q3 Revenues Increase 74 Percent Load More Breaking News Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering Dante Labs to Refund COVID-19 Test Customers Following UK Regulatory Investigation Lifespan Linked to Lower Protein Synthesis Gene Expression Pathogenic Variants in Disease-Causing Genes Have Low Penetrance on Average, Study Finds The Scan Sensor to Spot SARS-CoV-2 Exposure Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register. Watching BA.2 A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says. Vermont Weighs Genetic Discrimination Bill VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information. PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.